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ProgenitorPrecisely controlled progenitor proliferation is essential for normal development. However, molecular
mechanisms, which control the correct timing of cell cycle withdrawal during development, have been
poorly understood. We show here that ubc9, a sumo-conjugating enzyme, controls the cell cycle exit of
retinal progenitors. We found that ubc9 is highly expressed in retinal progenitors and stem cells in Xenopus
embryos. Ubc9 physically and functionally associates with Xenopus hmgb3, which is required for retinal cell
proliferation, and prolonged expression of ubc9 and hmgb3 results in suppression of the cell cycle exit of
retinal progenitors in a sumoylation-dependent manner. Overexpression of ubc9 and hmgb3 decreased
expression of the cell-cycle inhibitor p27Xic1. Furthermore, progenitor proliferation is regulated, at least in
part, by sumoylation of transcription factor Sp1. These results suggest a signiﬁcant role of sumoylation for
cell cycle regulation in retinal progenitors.tal Biology, Osaka Bioscience
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The vertebrate neural retina is a complex sensory tissue whose
function depends on the production of a sufﬁcient number of cells
of each retinal cell type and the correct formation of laminar
cytoarchitecture. The seven major cell types that compose the neural
retina arise from a pool of multipotent progenitors (Young, 1985;
Cepko et al., 1996). Birthdating studies have demonstrated that the
seven retinal cell types are generated in an evolutionarily conserved
order during development, although multiple cell types are simulta-
neously produced at any given developmental stage (Cayouette et al.,
2006; Cepko et al., 1996). Therefore, retinal progenitor cells stop
proliferation to differentiate into the cell types that are generated
earlier, but also proliferate extensively at an appropriate rate to
produce a sufﬁcient number of later cell types. Thus, cell proliferation
and cell differentiation occur in parallel in the developing vertebrate
retina (Cepko et al., 1996; Donovan and Dyer, 2005; Harris, 2009;
Levine and Green, 2004; Young, 1985). A number of extrinsic cues,
including Wnt, Hedgehog and Notch signaling pathways have been
implicated in the control of retinal progenitor proliferation and
differentiation in the developing retina (Denayer et al., 2008; Dorsky
et al., 1997; Van Raay et al., 2005; Wallace, 2008). On the other hand,
the signiﬁcance of the cell-intrinsic program has been suggested bythe clonal density culture of retinal progenitor cells from the rat retina
at embryonic day 17.5 (E17.5) (Cayouette et al., 2003). A number of
homeodomain transcription factors have been implicated in the
control of retinal progenitor proliferation, including rax/Rx, Pax6,
Chx10, Six3, six6/optx2 and Prox1. They are involved in the regulation
of cell fate competency, cell proliferation and cell differentiation of
retinal progenitors (Burmeister et al., 1996; Casarosa et al., 2003; Dyer
et al., 2003; Furukawa et al., 2000; Green et al., 2003; Li et al., 2002;
Marquardt et al., 2001; Zuber et al., 1999). However, molecular
mechanisms controlling the balance of two opposing cell behaviors,
cell proliferation and cell cycle exit during development, remain to be
elucidated.
Cyclin-dependent kinase inhibitors (CKI) play a signiﬁcant role
in the regulation of the cell cycle. Two families of Cdk inhibitors, the
Cip/Kip family, which includes p27Kip1, p21Cip1 and p57Kip2, and the
Ink4 family, comprised of p16Ink4a, p15Ink4b, p18Ink4c and p19Ink4d,
have been identiﬁed. CKI can inhibit the various cyclin-Cdk complexes
that control G1 progression and entry into the S phase, and its
overexpression in various cell lines arrests the cell cycle in G1 (Besson
et al., 2008; Sherr and Roberts, 1999). Inmice p27Kip1 regulates the cell
cycle withdrawal of late retinal progenitor cells, and in Xenopus
p27Xic1 regulates cell cycle exit and Müller glia development in the
developing retina (Levine et al., 2000; Ohnuma et al., 1999).
Sumoylation is a highly conserved evolutionary pathway, from
yeast to vertebrates. Ubc9 is the only known small ubiquitin-related
modiﬁer (sumo) E2-conjugating enzyme. In Saccharomyces cerevisiae,
ubc9 depletion results in cell cycle arrest at the G2/M phase (Seufert
et al., 1995). By contrast, in Schizosaccharomyces pombe, the hus5
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high levels of abortive mitosis and chromosome missegregation (al-
Khodairy et al., 1995). RNAi-mediated knockdown of ubc9 in
Caenorhabditis elegans results in embryonic arrest after gastrulation
and pleiotropic defects in larval development such as vulval eversion
at the fourth larval stage and abnormal tail morphology (Jones et al.,
2002). In Drosophila melanogaster, the ubc9 lethal mutant, known as
lesswright, dominantly suppresses the nondisjunction and cytological
defects of female meiotic mutations that affect spindle formation
(Apionishev et al., 2001). In zebraﬁsh, ubc9 regulates mitosis and cell
survival during development. Loss of ubc9 leads to compromised
mitosis and cellular overgrowth, and ubc9 is required for tissue-
speciﬁc cell viability in zebraﬁsh (Nowak and Hammerschmidt, 2006).
In mice, the ubc9-mediated sumo pathway is essential for nuclear
integrity and chromosome segregation (Nacerddine et al., 2005). Sumo
post-translationally modiﬁes many proteins with roles in diverse
processes including regulation of transcription, chromatin structure,
DNA repair, protein localization, and protein activity (Geiss-Friedlander
and Melchior, 2007; Hay, 2005; Johnson, 2004). It was reported that
neural crest precursor formation is regulated by sumoylation of SoxE
in Xenopus, resulting in a change in the physiological role of the
SoxE protein (Taylor and Labonne, 2005). Recently, it was also reported
that sumoylation has an important role in retinal photoreceptor
differentiation (Onishi et al., 2009). However, the exact role of ubc9 in
retinal development remains to be elucidated.
Rax/Rx is a transcription factor that is predominantly expressed in
retinal progenitors and is essential for eye development in vertebrates
(Furukawa et al., 1997; Mathers et al., 1997). Rax is conserved among
species, including human, mouse, chicken, ﬁsh and Xenopus. We
previously demonstrated that Xenopus high mobility group box 3
(hmgb3) is one of the downstream factors of rax (Terada et al., 2006).
Overexpression and loss-of-function experiments have indicated that
hmgb3 has a signiﬁcant role in retinal progenitor proliferation during
eye development in Xenopus. Hmgb3 is an evolutionally conserved
nuclear proteinwithout a transactivation domain and has been thought
to function as a chromatin modulator, suggesting that hmgb3 functions
through a protein complex. In the current study, we identiﬁed ubc9,
a sumo conjugating enzyme, to be an interacting partner of hmgb3.
We demonstrated that ubc9 regulates retinal progenitor proliferation
in a hmgb3-dependent manner, at least in part, via the suppression
of p27Xic1 expression through Sp1 sumoylation. Our results suggest
that protein sumoylation plays an important role in controlling retinal
progenitor proliferation.Materials and methods
Yeast two-hybrid assays
We carried out a yeast two-hybrid screen using MATCHMAKER
GAL4 Two-Hybrid System 3 (Clontech). The AH109 yeast strain
bearing the bait plasmid pGBKT7-hmgb3 was transformed with the
mouse retinal (Postnatal day 0 (P0)-P3) cDNA library in a pGADT7
vector. Initially, about 400,000 clones were screened. Yeast colonies
that grew at 30 °C on SD-Trp-Leu-His were re-streaked on SD-Trp-
Leu-His-Ade (218 colonies). Streaked yeast colonies that grew on SD-
Trp-Leu-His-Ade (121 colonies) were subjected to the β-galactosidase
(β-gal) assay. 24 colonies were positive in the β-gal assay. Rescued
plasmids from yeast into Escherichia coli strain DH5α were classiﬁed
by enzyme digestion pattern. Each representative plasmid was re-
introduced into the yeast strain AH109 together with pGBKT7-hmgb3
to conﬁrm the reproducibility and speciﬁcity of interactions. Seven
clones were obtained and six of them were ubc9 cDNAs. The amino
acid sequences of mouse ubc9 and Xenopus ubc9 are identical.
Therefore, the mouse ubc9 cDNA was used for overexpression
experiments using Xenopus embryos.Embryo manipulations
Embryos were obtained from Xenopus laevis adult frog by hormone-
induced egg laying and in vitro fertilization. Embryos were staged
according to Nieuwkoop and Faber (1994). Glucocorticoid receptor
fusion proteins were activated by adding 25 μM dexamethasone (DEX)
(Sigma, D1756) into the culture medium. Injected embryos were
raised at 15 °C. Xenopus embryos were abdominally injected with 5-
Bromo-2'-deoxy-uridine (BrdU) (20 mM) for BrdU labeling.
RNA synthesis and RNA microinjection
Capped RNAs were synthesized using the MESSAGE mMACHINE
kit (Ambion). One animal dorsal blastomere was injected for
phenotype observations at the 8-cell stage. The amount of injected
synthetic RNAs were as follows; 75 pg of lacZ, 100 pg of EGFP, 225 pg
of hmgb3, 250 pg of hmgb3 (mut), 100 pg of ubc9, 200–800 pg of ubc9
(C93A), 200 pg or 400 pg of sumo-Sp1-GR, 800 pg of Sp1(17-723)-GR,
400 pg of Sp1-GR.
X-gal staining and in situ hybridization
Embryos were grown to a desired stage and ﬁxed in MEMFA
(0.1 MMOPS (pH 7.4), 2 mM EGTA, 1 mMMgCl2, 3.7% formaldehyde)
for 30 min and transferred into the X-gal staining solution until
staining was apparent. In situ hybridization was performed essentially
as described (Harland, 1991). RNA probes of Xenopus hmgb3 and
Xenopus rax were previously described (Terada et al., 2006).
Quantiﬁcation of enlarged eye size
Embryos injected with synthetic RNA were grown to stage 37/38
and ﬁxed in MEMFA followed by X-gal staining. Quantiﬁcation of
enlarged eye was performed as previously described (Terada et al.,
2006). The eye diameters were measured by Image J and used to
calculate the percent increase in eye diameter on the injected side to
the un-injected side. The epidermis overlaying the eye was removed.
Animal cap dissections
Animal caps were dissected from stage 8/9 embryos in 0.5x MMR
(Marc's Modiﬁed Ringer's solution). The caps were incubated until
sibling embryos reached stage 19/20 and then subjected to further
analysis.
Immunohistochemistry
Immunostaining of frozen sections was performed essentially as
described previously withminor modiﬁcations (Terada et al., 2006). A
blocking solution containing 0.2% of TritonX-100 was used. Sections
were incubated for 1 h in 2N HCl prior to BrdU immunodetection. For
immunostaining, anti-β-galactosidase (β-gal) antibody (Promega,
#Z3781), anti-phospho-histone H3 antibody (Upstate, #06-570), anti-
BrdU antibody (Fitzgerald, #20-BS17), anti-calbindin (calbiochem
#PC253L), anti-islet1 (DSHB, clone 39.4D5), and anti-PCNA antibody
(DAKO, M0879) were used for primary antibodies, Cy3-conjugated-
anti-rabbit IgG (Jacson ImmunoResearch Laboratories, #711-165-
152), Cy3-conjugated-anti-mouse IgG (Jacson ImmunoResearch Labo-
ratories, #711-165-150), Alexa Fluor 488-conjugated-anti-sheep
IgG (Invitrogen, #A11015) and Alexa Fluor 488-conjugated-anti-
mouse IgG (Invitrogen, #A11001) were used for secondary antibodies.
For immunoprecipitation and Western blots, anti-HA antibody (Santa
Cruz, #sc-805), anti-myc antibody (Santa Cruz, #sc-40), anti-FLAG
antibody (M2) (Sigma, #F3165) were used.
Fig. 1. Ubc9 interacts with hmgb3, and ubc9 mRNA shows a similar expression pattern with that of hmgb3 mRNA. (A, B) Analysis of interaction between hmgb3 and ubc9 by yeast
two-hybrid assay. Strength of interaction of deletion constructs of hmgb3 (A) or ubc9 (B) are represented. +++, ++, + reﬂect on the extent of the ability to grow on medium
lacking adenine and histidine. (C–N) Expression of ubc9 and hmgb3 in developing Xenopus embryos. Expression of ubc9 (C–E, I–K) or hmgb3 (F–H, L–N) was analyzed by whole
mount in situ hybridization (C–H) followed by producing the frozen sections (I–N) at stages indicated in each panel. Ubc9 or hmgb3 is expressed in the optic vesicle (I, L), in the
developing retina (J, M), and in the CMZ in the post embryonic retina as indicated by yellow arrows (K, N). Scale bar, 100 μm.
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DNA was lipofected into the anterior neural fold of stage 18
embryos as previously described (Dorsky et al., 1997). EGFP DNA was
co-lipofected to mark the lipofected cells. Embryos were ﬁxed at stage
41 and sectioned at a thickness of 10 μm. EGFP-positive cells were
counted and the cell type was identiﬁed based upon their laminar
position and morphology as previously described (Dorsky et al.,
1997).Fig. 2. Ubc9 and hmgb3 are functionally associated in eye development in Xenopus. (A–L) X
above each panel (A–C, E', G–K), and harvested at stage 37/38 followed by X-gal staining. Em
view with anterior to the top (A'–C', E', and G'–K'). Injected side is indicated by β-gal activity
the injected side and the uninjected side (D–F, L). Data are means from three experiments w
(n) and the mean of the ratio of eye size between injected side and uninjected side (r): lacZ, (
(31, 0.93), (31, 0.88) (D), lacZ/hmgb3, (n, r)= (34, 1.06), (36, 1.02), (32, 1.05) (E) and lacZ/u
the injected side and the uninjected side were classiﬁed as indicated in the right side of (F)
diameter between the injected side and the uninjected side were classiﬁed as indicated at th
indicate reduced eye size (C', J'). Yellow arrow indicates the enlarged eye (E').Analysis of nuclear density, cell death, and BrdU-positive or
phospho-histone H3 (pH3)-positive cells
Embryos were harvested at stages 32/33, 33/34, 35/36, 40 or 41
and ﬁxed in MEMFA. Cryosections (10 μm) were made from embryos
and subjected to nuclear density analysis (stage 40), TUNEL (TdT-
mediated dUTP Nick-End Labeling) assay (stage 33/34 or 35/36)
using the in situ Apoptosis Detection Kit (TAKARA), immunostaining
for BrdU (stages 40 and 41) or for pH3 (stage 32/33 and stage 33/34).enopus embryos were injected with synthetic RNAs or morpholino oligos as indicated
bryos are represented as lateral views with anterior to the left (A–C, G–K) and as dorsal
in blue (A–C', E', G–K'). Diameters of the eyes of each embryo were compared between
ith the numbers indicated as follows±s.e.m. (D–F). The numbers of embryos analyzed
n, r)=(31, 1), (30, 0.99), (34, 1) (D–F), lacZ, ubc9 (93A) plus hmgb3, (n, r) = (31, 0.94),
bc9 (93A), (n, r)=(36, 1), (31, 0.99), (33, 0.99) (F). Differences in eye diameter between
and the ratio of each class to the total number are indicated (D–F). Differences in eye
e right side and the ratio of each class to the total number is indicated (L). Green arrows
184 K. Terada, T. Furukawa / Developmental Biology 347 (2010) 180–194DAPI-positive cells in an arbitrary unit area (in the inner nuclear
layer) were counted and cell density was calculated. TUNEL assay was
performed according to the instruction manual protocol. The number
of apoptotic cells and DAPI-positive signals were counted, and
percentages of apoptotic cells were calculated. The number of BrdU-
positive cells and DAPI-positive signals were counted, and percen-tages of BrdU-positive cells were calculated (stage 32/33) or BrdU-
positive cells were counted (stages 40 and 41). To examine the ratio of
the number of pH3-positive cells to the total number of cells, the
number of pH3-positive cells and DAPI-positive signals were counted,
and percentages of pH3-positive cells were calculated. To examine the
ratio of the number of BrdU-labeled cells to the total number of cells,
185K. Terada, T. Furukawa / Developmental Biology 347 (2010) 180–194three adjacent serial sections corresponding to the central retina were
prepared. One of the these sections was stained with an anti-BrdU
antibody, one was stained with DAPI, and the third was stained with
an anti-β-gal antibody, since HCl treatment makes DAPI staining of
nucleus and anti-β-gal staining inefﬁcient. The serial sections in
which almost all retinal cells were stainedwith an anti-β-gal antibody
were used for subsequent analysis. Each analysis was conducted on
three to nine eyes for each experiment, and for each eye the average
value was calculated from two to three sections.Analysis of cell differentiation by immunohistochemistry of
BrdU-incorporating cells in the developing retina
Embryos injected with lacZ or lacZ/ubc9/hmgb3 RNAs at the
eight cell stage were injected with BrdU at stage 40/41. Injected
embryos were raised to stage 46 and harvested. Retinal sections
were co-immunostained with an anti-BrdU antibody and antibodies
to retinal neuron markers. Image acquisition and analysis of the
signals obtained were performed using Zeiss Confocal LSM510
Microscope.Immunoprecipitation assay, sumoylation assay and Western blots
293T cell lysates or Xenopus embryo lysates, which were injected
with synthetic RNAs, were prepared in immunoprecipitation (IP)
buffer (50 mM Tris•HCl, pH 7.5, 1 mM EDTA, 2 mM MgCl2, 150 mM
NaCl, 1 mM Phenylmethylsulfonyl ﬂuoride, 0.5% TritonX-100) in the
presence of protease inhibitor tablets (Roche) and spun at 17,400g
for 10 min at 4 °C. N-ethylmaleimide was added (20 mM) to IP buffer
when sumoylation of proteins were detected. The indicated anti-
bodies and Protein G sepharose (Amersham) were added to the
supernatants, and incubated at 4 °C overnight. The sepharose beads
were washed ﬁve times with IP buffer. Western blots were performed
with indicated antibodies.Real-time PCR
Total RNA was reverse-transcribed by Superscript II (Invitrogen)
using random primers. Real-time PCR was performed using the
Thermal Cycler Dice Real Time System (TAKARA) and SYBR GreenER
qPCR SuperMix Universal (Invitrogen), according to the manufac-
turer's protocols. Quantiﬁed RNA values were normalized with those
of ribosomal RNA. Quantitative analysis was performed at least three
times and shown with standard errors.Plasmids and PCR primers
Details of plasmid construction and the primer sequences used for
plasmid construction are available upon request.Fig. 3. Ubc9 and hmgb3 function synergistically in a hmgb3 sumoylation-independent man
(D) or lacZ/ubc9 (E) in Xenopus embryos. Embryos were harvested at stage 37/38 (A–E) an
enlarged eye (B). Diameters of the eyes were compared between the injected side and t
the uninjected side were classiﬁed as indicated in the right side of Fig. 2F, and the ratio of eac
with the numbers indicated as follows±s.e.m. (C–E). The numbers of embryos analyzed (n)
(n, r)=(32, 0.96), (31, 0.99), (38, 0.99) (C–E), lacZ, ubc9 plus hmgb3, (n, r)= (32, 1.12), (36, 1
(n, r)= (20, 1), (26, 0.98), (45, 1) (E). (F) The structure of hmgb3 and hmgb3 (mut). Lysine re
substituted with arginine residues (hmgb3 (mut)). (G–I) Overexpression of lacZ alone (G-I),
Embryos were harvested at stage 37/38 (G–I). The effects of genes of interest were analyze
as follows±s.e.m. (G–I). The numbers of embryos analyzed (n) and the mean of the ratio of e
(33, 1) (G-I), lacZ/ubc9/hmgb3 (mut), (n, r) = (37, 1.09), (32, 1.06), (30, 1.07) (G), lacZ/hmg
0.99), (31, 1) (I). (J) Embryos were injected with synthetic RNAs of indicated and harvested
SDS-PAGE andWestern blot analysis using an anti-FLAG antibody. Lysates of embryos were a
peptide antibody as a loading control. Asterisks indicate sumoylated bands. Arrows indicatResults
Ubc9 is expressed in the developing CNS in Xenopus embryos
We previously found that hmgb3 is essential for proliferation of
retinal progenitors (Terada et al., 2006). In the current study we
performed a yeast two-hybrid screen to identify a factor(s) that
interacts with hmgb3 protein in the context of retinal development. A
full-length hmgb3 coding sequence, fused in-frame to the yeast Gal4
DNA binding domain was expressed in the AH109 strain and this yeast
strain was used to screen a mouse retinal cDNA library fused with the
Gal4 activation domain. In this screen we identiﬁed ubc9 as an
interacting protein with hmgb3 (Fig. 1A, B). To conﬁrm the speciﬁcity
of hmgb3-ubc9 association, as well as to identify the region(s) of
hmgb3 responsible for the interaction, we constructed a series of
hmgb3 deletionmutants in the pGBKT7 vector (Fig. 1A) and expressed
each of these in AH109 yeast transformed with pGADT7-ubc9. The
ability to grow onmedium lacking adenine and histidine revealed that
hmgb3 has a ubc9-interacting domain in the N-terminal region (1-91
amino acids). We named this mutant hmgb3_1 (Fig. 1A). To identify
the region of ubc9 responsible for its interaction with the hmgb3
protein, we pursued a deletion-based interaction assay (Fig. 1B). We
observed that ubc9(93A), which is a inactive form of ubc9, can bind
to hmgb3, suggesting that enzymatic activity is not required for ubc9
to bind to hmgb3 (Fig. 1B). All partial fragments of ubc9 failed to
interact with hmgb3, suggesting that a full-length ubc9 is required
for interaction with hmgb3. We also detected ubc9 and hmgb3
interaction by co-immunoprecipitation assay using 293T cells
transfected with ubc9 and hmgb3 expression constructs (Supplemen-
tary Fig. S1). We then analyzed the expression pattern of ubc9
in developing Xenopus embryos, and found that ubc9 is expressed
mainly in the developing central nervous system (CNS) including the
developing retina (Fig. 1C–E, I, J). In the developing retina, ubc9
appeared to be expressed in retinal progenitors (Fig. 1I, J) and
restricted to the CMZ, where retinal stem cells reside, as development
proceeded (Fig. 1K). Thus, the expression pattern of ubc9 was similar
to that of hmgb3 in Xenopus embryonic development (Fig. 1C–N)
(Terada et al., 2006).
Ubc9 and hmgb3 are functionally associated in retinal development
We focused our analysis on the retina in the current study, although
ubc9 is expressed ubiquitously in the developing Xenopus CNS. Ubc9
has been reported to be expressed in the progenitor/stem cells in the
developing rat CNS as well (Watanabe et al., 2008), however, the roles
of ubc9 in progenitor/stem cells in the rat CNS are unknown. Thus,
we investigated a possible role of ubc9 in retinal progenitor/stem cells
by taking advantage of the Xenopus system so that we can perform
overexpression and/or loss-of-function experiments on several genes
simultaneously in order to evaluate functional interactions between
genes of interest.
Weﬁrst testedwhether or notubc9 sumoylation activity is required
for hmgb3 to induce eye enlargement using a sumoylation activity-ner. (A–E) Overexpression of lacZ alone (A, C–E), lacZ/ubc9/hmgb3 (B, C), lacZ/hmgb3
d injected side is indicated by β-gal activity in blue (A, B). Yellow arrow indicates the
he uninjected side (C–E). Differences in eye diameter between the injected side and
h class to the total number are indicated (C–E). Data are means from three experiments
and the mean of the ratio of eye size between injected side and uninjected side (r): lacZ,
.09), (41, 1.07) (C), lacZ/hmgb3, (n, r)= (31, 1.04), (31, 0.99), (38, 1.06) (D), lacZ/ubc9,
sidues with a high probability of sumoylation are represented. Four lysine residues were
lacZ/ubc9/hmgb3 (mut) (G), lacZ/hmgb3 (mut) (H) or lacZ/ubc9 (I) in Xenopus embryos.
d as in C–E (G–I). Data are means from three experiments with the numbers indicated
ye size between injected side and uninjected side (r): lacZ, (n, r)=(35, 0.98), (35, 0.99),
b3 (mut), (n, r) = (36, 1.05), (34, 1.02), (32, 1) (H), and lacZ/ubc9, (n, r) = (35, 1), (33,
at stage 28 followed by an immunoprecipitation (IP) assay using an anti-FLAG antibody,
liquoted before IP and used for SDS-PAGE,Western blotting, and probed with an anti-HA
e the heavy chain and light chain of mouse IgG.
Fig. 4. The effect of ubc9(93A) and hmgb3 on cell cycle and cell death. (A–E) Embryos were injected with synthetic RNAs at eight cell stage, harvested and processed at stage 33/34
(A-D), stage 35/36 (E). Injected RNAs are indicated on the left side (A–C) of each panel. Scale bar, 50 μm (A). (A–A''), (B–B'') and (C–C'') are the same section respectively. Antibodies
used in immunohistochemistry are indicated above each panel (A, B, C, A', B', C'). DAPI staining (A'', B'', C''). Phospho-histone H3-positive cells (D) and apoptotic cells (E) were
analyzed. Data aremeans±s.e.m. (D, E). (D) n=3 eyes, 10 sections (lacZ), n=3 eyes, 10 sections (lacZ/ubc9(93A)/hmgb3) and n=3 eyes, 10 sections (lacZ/ubc9(93A) (*P=0.013,
Student's t-test) (E) n=3 eyes, 6 sections (lacZ), n=3 eyes, 6 sections (lacZ/ubc9(93A)/hmgb3). Asterisks indicate statistical signiﬁcance determined by Student's t-test (*Pb0.05).
186 K. Terada, T. Furukawa / Developmental Biology 347 (2010) 180–194deﬁcient mutant of ubc9, ubc9 (C93A) (Nowak and Hammerschmidt,
2006). As we previously reported, upon hmgb3 overexpression, the
number of embryos which exhibited enlarged eye size compared to
that of lacZ-injected embryosmodestly increased (Figs. 2A, A', E, E' and
3D) (Terada et al., 2006). While strong inhibition of ubc9 by 800 pg
of ubc9(93A) injection resulted in small eyes (Supplementary Fig. S2A,
B), weak inhibition of ubc9 function by injection of a small amount of
ubc9 (93A) RNA (200–500 pg) did not cause a signiﬁcant effect on eye
development (Fig. 2B, B', F, H, H', L). Therefore, we injected 200 pg of
ubc9(93A) and hmgb3 to examine the functional interaction between
ubc9(93A) and hmgb3. We observed that it was sufﬁcient for the
suppression of hmgb3-induced eye enlargement (Fig. 2C, C', D). More
than merely suppressing eye enlargement, co-injection of ubc9(93A)
and hmgb3 caused a reduction of eye size, suggesting that hmgb3
augmented the negative effect of ubc9(93A). We then performed
partial inhibition experiments of ubc9 and hmgb3 alone, or both
proteins together. We previously reported that 1 pmol of hmgb3
morpholino oligo (MO) injection results in a small eye phenotype
(Terada et al., 2006). Hmgb3 MO affects eye growth in a dose
dependent manner (Supplementary Fig. S3A–C). We induced a partial
inhibition of hmgb3 by injecting 0.2 pmol of hmgb3MO(Fig. 2G, G', J, J',
K, K'). The inhibition of each protein alone did not show a signiﬁcant
effect (Fig. 2G, G', H, H', L), and ubc9 (93A) and control MO did not
affect eye growth (Fig. 2I, I'), however, the inhibition of both ubc9 andFig. 5. Ubc9 and hmgb3 affect the cell cycle exit, but not cell density or cell death in the de
processed at stage 40 (A–C, H, I, K), stage 33/34 (D), stage 32/33 (E–G), stage 41 (J, J') and sta
side (E–E'', F–F'') of each panel. Scale bar, 50 μm (A), 100 μm (E'', I). The uninjected side i
Embryos were labeled with BrdU for 1 h before harvest (E–M). (J) and (J') are the same sectio
DAPI staining (A, B, E'', F''). BrdU-positive cells were analyzed (G, L, M). Arrowheads indicat
cells outside the CMZ (I, J). Data are means±s.e.m. (C, D, G, L, M). (C) n=3 eyes, 5 sections
ubc9), (G) n=3 eyes, 9 sections (lacZ), n=3 eyes, 9 sections (lacZ/hmgb3/ubc9), (L) n=6 e
test), (M) n=9 eyes, 29 sections (lacZ), n=5 eyes, 13 sections (hmgb3/ubc9 (93A)). (N–P)
sections were prepared at stage 41 and the numbers of EGFP-positive cells in cell clusters, wh
EGFP-introduced (N) and EGFP/ubc9/hmgb3-introduced retina (O). The average of the num
EGFP/ubc9/hmgb3: 22 retina, 499 cells) (*P=0.047, Student's t-test) (P). Data are means±hmgb3 resulted in reduced eye size (Fig. 2J, J', L), indicating that the
cooperative functioning of ubc9 and hmgb3 is essential for normal eye
growth in Xenopus. This effect was rescued by the co-injection of ubc9
(Fig. 2K, K', L). We previously demonstrated that the effect of the
hmgb3MOwas rescued by hmgb3 RNA injection (Terada et al., 2006).
These observations indicate that effects of hmgb3 MO and ubc9
(93A) were speciﬁc to each target. These results suggest that ubc9 and
hmgb3 are functionally associated in a sumoylation activity-dependent
manner to regulate eye growth.
Consensus sumoylation lysine residues are not required for functional
association between ubc9 and hmgb3
We next performed ubc9 and hmgb3 overexpession experiments.
Overexpression of both ubc9 and hmgb3 resulted in a high frequency
of enlarged eye size (Fig. 3A–C), while overexpression of hmgb3 or
ubc9 alone produced a weak effect on eye size (Fig. 3D, E, I). In
addition, ubc9/hmgb3 overexpression increased the mean eye size
compared with the mean eye size of the eyes overexpressing hmgb3
alone (Supplementary Fig. S4A). Functional cooperation between
ubc9 and hmgb3 suggests that the hmgb3 protein is modiﬁed by
sumoylation, leading to enhancement of progenitor proliferation.
Alternatively, ubc9 may regulate eye growth by sumoylation of other
target protein(s). In order to test this possibility we ﬁrst examinedveloping retina. (A–M) Embryos were injected with synthetic RNAs and harvested and
ges 40/41 (L, M). Injected RNAs are indicated above (B, H, I, J), below (J', K) or on the left
s indicated by “cont ” (A). Nuclear density (C) and apoptotic cells (D) were analyzed.
n. Antibodies used in immunohistochemistry are indicated above each panel (E, F, E', F').
e BrdU-incorporating cells in the CMZ (H–J, K) and arrows indicate BrdU-incorporating
(cont, hmgb3/ubc9), (D) n=3 eyes, 8 sections (LacZ), n=3 eyes, 5 sections (hmgb3/
yes, 18 sections (lacZ), n=4 eyes, 12 sections (hmgb3/ubc9) (**P=0.0022, Student's t-
Embryos were lipofected with expression construct into anterior neural region. Retinal
ich appear to be derived from a single retinal progenitor cell respectively, were counted.
ber of cells in each cell cluster (clone size) was calculated (EGFP: 22 retina, 478 cells;
s.e.m. re: retina ; le: lens; rpe: retinal pigment epithelium.
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lysine residues that are positioned in the consensus motif of
sumoylation and one lysine residue with a high probability of
sumoylation (http://www.abgent.com/doc/sumoplot; Fig. 3F). We
transfected 293T cells with ubc9, hmgb3 and sumo-1 expression
vectors. We did not detect signiﬁcant sumoylation of hmgb3 (data notshown). We next substituted the four lysine residues of hmgb3 with
arginine resides by mutagenesis to make hmgb3 (mut) (Fig. 3F). This
substitution resulted in little effect on the cooperative function
between ubc9 and hmgb3 for eye growth (Fig. 3C, G; Supplementary
Fig. S4B). The effect of hmgb3 (mut) on eye enlargement was also
similar to that of hmgb3 (Fig. 3H; Supplementary Fig. S4B), suggesting
188 K. Terada, T. Furukawa / Developmental Biology 347 (2010) 180–194that hmgb3 is not a sumoylation target of ubc9. In order to examine if
ubc9 sumoylates proteins other than hmgb3, we overexpressed ubc9,
ubc9(93A), FLAG-tagged sumo-1 or HA-tagged hmgb3 in Xenopus
embryos, followed by SDS-PAGE and Western blots. We observed
an enhanced sumoylation by ubc9 overexpression (Fig. 3J). These
results showed that ubc9 and hmgb3 act in an hmgb3 sumoylation-
independent manner, implying that ubc9 exerts sumo-modifying
actions on protein(s) other than hmgb3 to regulate eye growth.
Overexpression of ubc9 and hmgb3 suppresses cell cycle exit of retinal
progenitor cells
Overexpression of both ubc9(93A) and hmgb3 resulted in reduced
eye size (Fig. 2C, C', D). We, therefore, examined whether cell cycle
arrest and/or apoptosis are induced in retinal progenitors as pre-
viously reported (Nowak and Hammerschmidt, 2006). In the retina
overexpressing ubc9(93A) and hmgb3 we observed that the ratio of
the number of phospho-histone H3 (pH3)-positive cells to the
number of total cells in the retina increased compared to that in
the lacZ-injected retina (Fig. 4A–B'', D), while 200 pg of ubc9(93A)
alone showed little effect (Fig. 4C–C'', D), suggesting that cell cycle
arrest is induced by both ubc9(93A) and hmgb3. We also observed an
increase in the number of apoptotic cells in the retina overexpressing
ubc9(93A) and hmgb3 (Fig. 4E).
On the other hand, we observed that overexpression of ubc9 and
hmgb3 resulted in an enlarged eye (Fig. 3A–C). The enlarged eye
phenotype observed upon overexpression of both ubc9 and hmgb3
might be due to their effects on the formation of the eye ﬁeld, cell death,
cell density, and/or cell proliferation. In order to investigate this point,
we examined the eye ﬁeld at stage 15/16 in ubc9 & hmgb3-injected
embryos, and we observed some embryos showed a subtle expansion
of the eye ﬁeld, while ubc9(93A) and hmgb3 have little effect (ubc9/
hmgb3, rax↑, in 5 of 14 embryos, Supplementary Fig. S5A–C). Therefore,
we also examined other eye ﬁeld genes, including pax6, optx2 and vsx1
(Supplementary Fig. S6).Wedidnot observe a signiﬁcant effect on those
genes (Supplementary Fig. S6A–I). These observations suggest that
ubc9 and hmgb3 overexpression does not have a signiﬁcant effect on eye
ﬁeld formation (Supplementary Figs. S5 and S6).We then examined cell
density in the retina by analyzing nuclear density, and did not observe
a signiﬁcant difference between injected eyes and uninjected eyes
(Fig. 5A–C). We then examined cell death by TUNEL assay. We failed
to observe a signiﬁcant difference between the ubc9/hmgb3-over-
expressed retina and the control retina (Fig. 5D). We next analyzed cell
proliferation by labeling proliferating progenitor cells using BrdU. We
injected Xenopus embryos with BrdU at stage 32/33 when almost all
cells in the retina are mitotic retinal progenitors (Fig. 5E–G) (Holt et al.,
1988). The ratio of the number of BrdU-positive cells to the number of
total cells was not signiﬁcantly different between the ubc9/hmgb3-
overexpressed retina (Fig. 5F-F'', G) and the control retina (Fig. 5E–E'',
G). In addition, the ratio of the number of pH3-positive cells to the
number of total cells (Supplementary Fig. S9A–C) and the ratio of
the number of pH3-positive cells to the number of proliferating cell
nuclear antigen (PCNA)-positive cells (proliferating cells) (Supplemen-
tary Fig. S9D–H) were not signiﬁcantly different between the ubc9/
hmgb3-overexpressing retina and the control retina (Supplementary
Fig. S9A–H). These results suggest that the cell cycle itself was not
largely affected. We next labeled Xenopus embryos with BrdU at stage
41 when retinal development is almost completed and, therefore,
proliferating progenitor/stem cells are observed only in the CMZ at this
stage.Weobserved fewproliferating cells outside theCMZ in the control
retina (Fig. 5H). In contrast, we observed a signiﬁcantly increased
number of proliferating cells outside the CMZ in the ubc9/hmgb3-
injected retina (Fig. 5I, J, J', L), suggesting that cell cycle exit of retinal
progenitors is suppressed. We did not observe an increase of BrdU-
positive cells in the hmgb3/ubc9 (93A)-injected retina (Fig. 5K, M). We
next examined whether ubc9 and hmgb3 act cell-autonomously. Welipofected EGFP alone or EGFP/ubc9/hmgb3 into retinal progenitors
and observed an increase in the clone size in the EGFP/ubc9/hmgb3-
overexpressing retina compared to that observed in the EGFP-over-
expressing retina (Fig. 5N–P), indicating that ubc9 and hmgb3 inhibit
the cell cycle exit of retinal progenitors in a cell-autonomous manner.
We also examined the timing of when the enlarged eye phenotype
manifests. We observed an enlarged eye phenotype at around stage
35/36 by visual inspection. Before stage 35/36, it is difﬁcult to
measure the eye sizes of embryos, therefore we examined the timing
of the larger eye phenotype manifestation itself by whole mount in
situ hybridization using eye marker genes, including rax/Rx, pax6 and
six3 at earlier stages than stage 35/36. We observed that an
enlargement of the eye region began after stage 28 (Supplementary
Fig. S7A–O). Since it is known that retinal neurons begin to be
generated after stage 26 in Xenopus, our observation that eye regions
represented by eye marker gene expression expanded after stage 28
would be consistent with the idea that ubc9/hmgb3 affect cell cycle
exit, leading to an enlarged eye phenotype.
The effect of ubc9 and hmgb3 on cell fate in the developing retina
We observed proliferating cells in the ubc9/hmgb3-overexpressing
retina at stages 40/41 (Fig. 5I, J, L), and then examined whether the
proliferating cells at stage 41 can differentiate into retinal neurons.
We injected Xenopus embryos, which had been injected with lacZ
alone or lacZ/ubc9/hmgb3, with BrdU at stage 41 to label proliferating
cells and harvested the embryos at stage 46. We subsequently
performed immunostaining of retinal sections with antibodies to
BrdU and markers of retinal neurons, such as calbindin (Fig. 6A–H) or
islet1 (Fig. 6I–L).We observed co-staining of BrdU and retinal markers
in the lacZ/ubc9/hmgb3-overexpressing retina (Fig. 6A–D', K, L), but
not in the lacZ-overexpressing retina (Fig. 6E–H, I, J), suggesting that
ubc9/hmgb3-induced proliferating cells were retinal progenitor cells.
We next examined whether ubc9/hmgb3 affects the cell fate decision
in the developing Xenopus retina. We did not observe a signiﬁcant
effect on cell fate decision by ubc9 and hmgb3 overexpression in the
developing Xenopus retina (Fig. 6M, N).
Overexpression of ubc9 and hmgb3 suppresses the p27Xic1 expression in
the developing retina
Several cell cycle regulators have been reported to play signiﬁcant
roles in retinal development (Donovan and Dyer, 2005; Levine and
Green, 2004). Among cell cycle regulators, CKI genes, including
p27Kip1, p57Kip2, p19, gadd45γ and p27Xic1, have been demonstrated to
play signiﬁcant roles in eye growth in mice and Xenopus. Only p27Xic1,
p19 and gadd45γ genes have been identiﬁed so far in Xenopus. We
examined the effects of ubc9 and hmgb3 on the expression of CKI
genes in the retina, where the injected side was identiﬁed by EGFP
ﬂuorescence (Fig. 7A–B'). We found that while injection of EGFP did
not affect on the expression of p27Xic1, a CKI gene (Fig. 7C, D), p27Xic1
expression was severely attenuated in the retina overexpressing both
ubc9 and hmgb3when examined bywholemount in situ hybridization
(Fig. 7E–H) (EGFP, p27Xic1↓, in 1 of 30 embryos; EGFP/ubc9/hmgb3,
p27Xic1↓, in 14 of 33 embryos). To conﬁrm the attenuation of p27Xic1
expression in the developing retina, we prepared retinal sections after
whole mount in situ hybridization to detect p27Xic1 expression. We
observed that p27Xic1 expression was attenuated in the developing
retina overexpressing lacZ, ubc9 and hmgb3, while not in the retina
overexpressing lacZ alone (Fig. 7K, L). We next examined the timing
of when the attenuation of p27Xic1 expression appears upon ubc9 and
hmgb3 overexpression. In the eye, the expression of p27Xic1 can be
detected as early as stage 26 (Ohnuma et al., 1999). Therefore, we
examined the effect on p27Xic1 at stage 25/26 and detected decreased
expression of p27Xic1 at stage 25/26 (Fig. 7M) (EGFP/ubc9/hmgb3,
p27Xic1↓, in 19 of 45 embryos). On the other hand, we observed that
Fig. 6. The effect of ubc9 and hmgb3 on the neural potential of retinal progenitors. (A–L) Embryos were injected with lacZ or lacZ/ubc9/hmgb3 RNAs at eight cell stage and then were
injected with BrdU at stage 41 (A–H) or at stage 37/38 (I–L), subsequently harvested at stage 46. Antibodies used in immunohistochemistry are indicated above each panel (A, A', E),
and (B, B', F). DAPI staining (C, C' G). Merge (D, D', H). Merge of BrdU signal (Green) and islet1 signal (Red) as indicated on the right of panels (I–L). Injected RNAs are indicated on the
left side (A–L) of each panel. Scale bar, 100 μm (A). White arrows indicate BrdU-positive cells in (A'), calbindin-positive cells in (B'), DAPI-positive cells in (C'), and BrdU, calbindin
and DAPI-positive cells in (D'), and BrdU plus islet1-positive cells in (K) and (L). (M) Retinal section (stage 41) showing EGFP-positive cells (green) lipofected with EGFP construct.
(N) Percentage of retinal cell types observed in the retina lipofected with EGFP or EGFP/ubc9/hmgb3. n=591 cells from 5 retinas for EGFP, n=638 cells from 6 retinas for ubc9 and
hmgb3. Data are means±s.e.m. p, photoreceptor cell; b, bipolar cell; g, ganglion cell; a, amacrine cell.
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of p27Xic1 at stage 21/22 (Fig. 7N) (EGFP/ubc9(93A)/hmgb3MO, p27Xic1
↑, in 4 of 18 embryos), although the effect from inducing p27Xic1
expression was very small. We also examined the effect of the
overexpresson of hmgb3 alone on p27Xic1 expression, and observed
weaker effect on p27Xic1 expression than that of ubc9/hmgb3 over-
expression, suggesting ubc9 can enhance the effect of hmgb3 on p27Xic1
expression (EGFP/hmgb3, p27Xic1↓, in 6 of 38 embryos at stage 28; EGFP/
ubc9/hmgb3, p27Xic1↓, in 17 of 77 embryos at stage 28). We did not
observe a signiﬁcant ubc9 and hmgb3 effect on the expression of cell
cycle regulators including cyclinD1, cyclin A2, cyclin B1 and hairy2 byRT-PCR (data not shown).Wealso did not observe a signiﬁcantdifferenceof
CKI gene gadd45γ expression (Fig. 7I, J, EGFP/ubc9/hmgb3, gadd45γ ↓, in
1 of 20 embryos) (Decembrini et al., 2006), suggesting a selective gene
regulation of CKI genes is mediated by ubc9 and hmgb3. We also
examined the effect of ubc9 and hmgb3 on cell cycle inhibitor p21
expression by quantitative-PCR using total RNAs from animal caps
injected with hmgb3 or ubc9/hmgb3 (Supplementary Fig. S8). The
expression of p21 appeared to be affected by hmgb3 or ubc9/hmgb3,
although the differences of expressions of p21 in the control were not
statistically signiﬁcant (Supplementary Fig. S8). These results suggest
that hmgb3 and ubc9 affect p21 expression, leading to the inhibition of
Fig. 7. Ubc9 and hmgb3 overexpression attenuates the expression of cell cycle inhibitor
p27Xic1. (A–B') Xenopus embryos injected with EGFP RNA. Embryos injected in the left
side are collected (A). Bright ﬁeld (B) and EGFP ﬂuorescent images (B') of the same
embryo injected in the left side. (C–H) In situ hybridization showing p27Xic1 expression
in EGFP- (C, D) or EGFP/hmgb3/ubc9- (E–H) injected embryos. Green arrow indicates
the location of the eye (H). Pictures of same embryos at different magnitudes (E, G) and
(F, H). (I, J) gadd45γ expression. Stages 32/33 (A-J). (K, L) p27Xic1 expression in the
developing retina in Xenopus embryos. Embryos injected with lacZ (K) or lacZ/hmgb3/
ubc9 (L) were harvested at stage 33/34 followed by X-gal staining. After whole mount
in situ hybridization, cryosections were produced (K, L). Red brackets indicate regions
of RNA-injection (K, L). Scale bar, 50 μm (K). Note that p27Xic1 expression is attenuated
in the RNA-injected region in (L), while not in (K). (M, N) In situ hybridization showing
p27Xic1 expression in EGFP/ubc9/hmgb3- (M) or EGFP/ubc9(93A)/hmgb3MO- (N)
injected embryos. re: retina; le: lens.
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detect a signiﬁcant signal of p19 in the eye ofXenopus embryos bywhole
mount in situ hybridization (data not shown). These observations
suggest that ubc9 and hmgb3 regulate cell cycle inhibitor expression.
Role of sumoylated Sp1 in retinal growth
Sumoylation of transcription factors typically induces their
transcriptional repression (Gill, 2005). We examined Sp1 as a
candidate target of sumoylation, since it has been reported that Sp1
has potential sites to be sumoylated and is involved in cell cycle
regulation (Black et al., 2001; Spengler and Brattain, 2006; Wang
et al., 2008). First, we found that Sp1 is predominantly expressed
in the developing Xenopus CNS, including the eye (Fig. 8A–D).
Mammalian Sp1 can be sumoylated at the Lys16 residue (Spengler
and Brattain, 2006; Wang et al., 2008), and Sp1 also has this
sumoylatable Lys16 residue matching the sumoylation consensus
residues. Therefore, we next examined whether or not Xenopus
homolog of Sp1 can be sumoylated using 293T cells. We introduced
plasmid DNAs encoding proteins of interest into 293T cells followed
by SDS-PAGE and Western blot analysis (Fig. 8E, F). Sumo-modiﬁed
proteins have a ~20 kDa higher molecular weight compared with
unmodiﬁed proteins. We performed Western blot analysis and
observed a slower migrating Sp1 (1-723) isoform, whereas we did
not observe a slower migrating isoform of Sp1 (17-723) lacking the
16N-terminal amino acids containing the potential sumoylation Lys16
residue (Fig. 8E). These results indicate that Xenopus Sp1 can be
sumoylated (Fig. 8F). Fusion of a sumo moiety to transcription factors
mimics the effect of sumo that is covalently linked to proteins on a
native lysine (Ross et al., 2002; Shalizi et al., 2006). We fused sumo-1
(1-95), which lacks the last 6 amino acids including the sumo
hydrolase cleavage site, to Sp1 (17-723), creating sumo-Sp1. In order
to investigate a functional role of sumo-Sp1 in retinal progenitor/stem
cells, we fused sumo-Sp1 to the hormone-binding domain of
glucocorticoid receptor (GRHBD), creating sumo-Sp1-GR, whose
activity can be regulated by dexamethasone (DEX) (Fig. 8G). This
system has been used to conditionally activate transcription factors
during Xenopus embryogenesis (Suzuki and Hemmati-Brivanlou,
2000; Takebayashi-Suzuki et al., 2003). We examined the effect of
sumo-Sp1-GR injection on eye development after stage 25-28 with
DEX treatment. We observed an eye enlargement in DEX-treated
embryos on the injected side (Fig. 8I, J), while not in DMSO-treated
embryos (Fig. 8H, J). We next investigated the expression of p27Xic1 in
the sumo-Sp1-GR-injected embryos. We observed an attenuation of
p27Xic1 expression in the retina of DEX-treated embryos in the
injected side (Fig. 8L, N) (sumo-Sp1-GR, DEX, p27Xic1↓, in 6 of 20
embryos), while not in DMSO-treated embryos (Fig. 8K, M) (sumo-
Sp1-GR, DMSO, p27Xic1↓, in 0 of 12 embryos), indicating that sumo
fusion of Sp1 can repress p27Xic1 expression in the developing Xenopus
retina. On the other hand, we observed a reduced eye phenotype in
the embryos injected with un-sumoylable Sp1, Sp1(17-723)-GR, with
DEX treatment, but not in thosewith DMSO treatment (Fig. 8O, P). We
also examined the effect of sumo-Sp1-GR on retinal progenitor
proliferation. We injected sumo-fused Sp1-overexpressing embryos
with BrdU at stage 41.We observed BrdU-positive cells in the retina of
DEX-treated embryos, but not in DMSO-treated embryos, outside the
CMZ (Fig. 8Q–S), similar to the proliferating cells we observed in the
retina of ubc9/hmgb3-injected embryos (Fig. 5I, J, L). These results
suggest that sumo modiﬁcation regulates the cell cycle exit of
proliferating retinal progenitor cells in the developing Xenopus.
Roles of ubc9/hmgb3 and Sp1 in retinal growth
We performed hmgb3 MO/ubc9(93A) or hmgb3 MO/ubc9(93A)/
sumo-Sp1-GR injection into embryos. We observed an almost normal
eye size in embryos injected with hmgb3 MO/ubc9(93A)/sumo-Sp1-
Fig. 8. Xenopus Sp1 is modiﬁed by sumoylation and plays a signiﬁcant role in eye development. (A–D) Sp1 expression in developing Xenopus at stage 28 (A) and stage 32/33 (B–D).
Sp1 expression was analyzed by whole mount in situ hybridization (A and B) followed by sectioning (20 μm) (C, D). Sp1 expression is indicated by purple signal (A–D). White arrows
indicate the eyes (A, B). Scale bar, 200 μm (C), 100 μm (D). (E) Structures of HA-tagged Sp1(1-723) and HA-tagged Sp1(17-723), which lacks the sumoylation target Lys (K16)
residue. (F) Plasmid DNAs encoding each protein represented in (F) were introduced into 293T cells followed by SDS-PAGE andWestern blot. (G) Structure of fusion protein, sumo-
Sp1-GR. (H–J) Xenopus embryos injected with sumo-Sp1-GR RNA that were harvested at stage 37/38. DEX or DMSO treatment after the optic vesicle was formed (st.25-28) (H–J).
Injected side is indicated by β-gal activity in blue (H, I). Differences in eye diameter between the injected side and the uninjected side were classiﬁed as indicated in the right side of
(J) and the ratio of each class to the total number are indicated (J). (K–N) Embryos were injected with sumo-Sp1-GR RNA and harvested at stage 32/33 followed by in situ
hybridization after collecting embryos which were injected at left side. DEX or DMSO treatment was applied after the optic vesicle was formed (st.25–28) (K–N). Same embryos are
presented at different magnitudes (K, M) and (L, N). Yellow arrows indicate the location of the eyes (M, N). (O–S) Embryos were injected with synthetic RNAs, harvested and
processed at stage 37/38 (O, P), stage 41 (Q–S). Injected RNAs are indicated below (O, P) or on the left side (Q, R) of each panel. DMSO or DEX treatment was applied around stage 23.
DMSO-treated (O) and DEX-treated (P) embryos. Green arrow indicates reduced eye (P). Injected side is indicated by β-gal activity in blue (O, P). Embryos were labeled at stage 41
with BrdU for 1 h before harvest and subsequently immunohistochemistry was performed with anti-BrdU antibody with retinal sections (Q, R). Scale bar, 100 μm (Q). Yellow arrows
indicate BrdU-incorporating cells outside the CMZ (R). Data are means±s.e.m. (S). n=3 eyes, 9 sections (DMSO), n=3 eyes, 7 sections (DEX) (**P=0.028, Student's t-test) (S).
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injected with hmgb3MO/ubc9(93A) (Fig. 9A). We next performed lacZ
alone or lacZ/ubc9/hmgb3/Sp1(17-723)-GR injection into embryos.We observed an almost normal eye size in embryos injected with lacZ
alone (Fig. 9B). On the other hand, we observed an enlarged eye
phenotype in embryos injected with lacZ/ubc9/hmgb3/Sp1(17-723)-
Fig. 9. The role of ubc9/hmgb3 and Sp1. (A, B) Xenopus embryos were injected with
synthetic RNAs and/or MO as indicated below each graph (A, B), and harvested at stage
37/38 (A, B). Differences in eye diameter between the injected side and the uninjected
side were classiﬁed as indicated to the right side of the graph and the ratio of each class
to the total number is indicated (A, B). Ubc9(93A)/hmgb3 MO- or ubc9(93A)/hmgb3
MO/sumo-Sp1-GR-injected embryos were treated with DEX at around stage 24, and
harvested at stage 37/38 (A). lacZ/ubc9/hmgb3/Sp1(17-723)-GR-injected embryos
were divided into two groups, treated with DMSO or DEX at around stage 24, and
harvested at stage 37/38 (B).
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we observed a reduced eye phenotype in embryos injected with lacZ/
ubc9/hmgb3/Sp1(17-723)-GR when the embryos were treated with
DEX (Fig. 9B). These results suggest that Sp1 acts downstream of
ubc9/hmgb3 in Xenopus eye development.
Discussion
In this study we demonstrated that protein sumoylation activity
has a signiﬁcant role in the regulation of cell cycle exit in the
developing Xenopus retina. First, ubc9 is expressed in retinal
progenitors in the developing retina and subsequently its expression
is conﬁned to the CMZ, where retinal stem cells reside. Second, co-
injection of ubc9 and hmgb3 produced ectopic BrdU-positive dividing
cells in the retina at stage 41 in a sumoylation activity-dependent
manner, while BrdU-positive cells were not detected in the control
retina except in the CMZ. Third, the expression of a CKI gene, p27Xic1,
was attenuated upon overexpression of ubc9 and hmgb3. Fourth, we
found that the Xenopus homolog of mammalian Sp1 can be modiﬁed
by sumoylation, and sumo-fused Sp1 has a potential to negatively
regulate p27Xic1 expression.
Role of sumo modiﬁcation in retinal development
Post-translational proteinmodiﬁcations, including phosphorylation,
acetylation and ubiquitinylation have been known to act like a switch
to activate or inactivate a protein or a protein complex in a cellular
context-dependentmanner. Recently, emerging evidence indicates that
protein sumoylation modulates protein function, including the regula-tion of transcription factors and the subcellular localization of proteins,
to control a wide variety of cellular events (Geiss-Friedlander and
Melchior, 2007; Hay, 2005; Johnson, 2004). We found that ubc9 is
expressed in retinal progenitor cells. In our experiment, a prolonged
expression of ubc9 and hmgb3 suppressed cell cycle exit, resulting in
retinal progenitor proliferation outside the CMZ at stages 40/41 when
progenitor proliferation is not normally observed. This observation
suggests that protein sumoylation plays an essential role as a functional
switch to control the cell cycle exit in retinal development.
The molecular events that determine the timing of “ON” and “OFF”
sumo modiﬁcation by affecting ubc9 expression in the retinal
progenitors have been unknown. Ubc9 expression may decrease
with different speeds among progenitors. Alternatively, there may be
mechanisms that allow selected cells to receive extrinsic signals,
leading to the regulation of sumo modiﬁcation in the cells that
received the signal. However, further investigation will be required to
examine these possibilities.
Role of Ubc9 in cell cycle regulation
It has been demonstrated that functions of CENP-E and TopII are
controlled by sumoylation, leading to the proper regulation of
chromosome segregation and subcellular localization of proteins
during the G2/M phase of the cell cycle in animal cells (Dawlaty et al.,
2008; Zhang et al., 2008). In zebraﬁsh, ubc9 is required for G2/M
progression of progenitor cells in the developing retina at late
developmental stages (Nowak and Hammerschmidt, 2006). However,
the role of ubc9 other than cell cycle regulation of the G2/M phase has
been poorly understood. It may be that cell cycle arrest at the G2/M
phase in an ubc9 loss-of-function experiment makes it difﬁcult to
analyze the function of sumoylation during other phases in the cell
cycle. Indeed, we also observed that ubc9(93A)/hmgb3 overexpres-
sion appeared to confer a negative effect on eye growth.
An analysis of ubc9 functions in the cell cycle by overexpression
experiments has not been reported as far as we know. We found that
overexpression of ubc9 and hmgb3 affected BrdU uptake in retinal
progenitors at stages 40/41 and also found that overexpression of
ubc9 and hmgb3 in retinal progenitors resulted in an increase in the
clone size. Considering these ﬁndings, ubc9may have a signiﬁcant role
in the control of cell cycle withdrawal in retinal progenitors.
In the hematopoietic system, hmgb3 regulates the balance
between hematopoietic stem cell (HSC) self-renewal and differenti-
ation (Nemeth et al., 2006). Hmgb3 is required for the transition of
HSCs to progenitor cells, including common lymphoid progenitors
and common myeloid progenitors. We observed that hmgb3 over-
expression can induce c-myc expression in Xenopus explant cultures
(Terada et al., 2006). We examined whether ubc9 can enhance c-myc
expression induced by hmgb3, but we observed little effect by ubc9 on
c-myc expression, suggesting that ubc9 regulates progenitor prolifer-
ation by a mechanism other than the regulation of c-myc expression
(data not shown). Although we suggested that ubc9 and hmgb3
inhibit the cell cycle exit of retinal progenitor cells, it remains to be
addressed whether proliferating cells at later stages (stages 40/41)
overexpressing ubc9/hmgb3 contain a population of cells possessing
stem cell characteristics created by inhibiting the transition of retinal
stem cells to retinal progenitors.
Role of Sp1 in retinal growth
Recently it was shown that Sp1 is sumoylated at N-terminus in
mammalian cells, which negatively regulates Sp1 transcriptional
activity (Spengler and Brattain, 2006). Sumoylation of Sp1 was also
reported to induce translocation of Sp1 to the cytosol and to induce
proteolysis of Sp1 (Wang et al., 2008). Sp1 is known to be involved
in the expression of cell cycle inhibitors, including p27Kip1 and p21Cip1.
A study using siRNA against p27Kip1 has demonstrated that Sp1 is
193K. Terada, T. Furukawa / Developmental Biology 347 (2010) 180–194required to increase the expression of p27Kip1 through protein G kinase
signaling (Cen et al., 2008). The attenuation of p27Xic1 expression by
hmgb3 and ubc9 overexpression in the present studymay bemediated
by Sp1 degradation, leading to a low level of p27Xic1 expression,
although it was not completely clear whether or not this attenuation is
mediated by active repression by sumo-modiﬁed Sp1. It is known that
Sp3 also recognizes the sameGC-rich sequence towhich Sp1 binds and
that Sp3 is modiﬁed by sumoylation resulting in repression of
transactivator activity (Ross et al., 2002). Our observation that the
effect caused by hmgb3 and ubc9 is stronger than the effect caused by
sumo fusion Sp1 mutants may suggest the existence of another target
of ubc9 sumoylation in retinal development.
Interaction between hmgb3 and ubc9
Hmgb3 and ubc9(93A) overexpression caused a reduced eye
phenotype, while hmgb3 and ubc9 overexpression resulted in an
enlarged eye phenotype. In contrast, overexpression with 100 pg of
ubc9 or 200 pg of ubc9(93A) alone showed little effect on Xenopus eye
development. Our results strongly suggest that hmgb3 augmented
both the negative effect of ubc9(93A) and positive effect of ubc9 on
eye growth. We also observed cell cycle arrest at the G2/M phase and
apoptosis in the ubc9(93A)/hmgb3-overexpressing retina, but not in
the retina injected with 200 pg of ubc9(93A) only. This may be due to
the augmentation of ubc9(93A) function by hmgb3, as the loss-of-
function of ubc9 induces cell cycle arrest and apoptosis in the
developing retina (Nowak and Hammerschmidt, 2006). These results
may reﬂect the functional interaction between hmgb3 and ubc9.
There have been studies demonstrating that a sumo E3 ligase
induces cellular responses, including cell senescence, apoptosis and
cell morphogenesis with ubc9 (Bischof et al., 2006; Shalizi et al.,
2007). These observations raise the possibility that ubc9 may require
a co-factor(s) including E3 ligase to induce these various cellular
responses. Therefore, we tested the possibility that hmgb3 acts as a
sumo E3 ligase. We transfected 293T cells with HA-Sp1, sumo-1, ubc9
and/or hmgb3 expression constructs. As far as we examined, we failed
to obtain evidence that hmgb3 acts as a sumo E3 ligase (data not
shown). Although hmgb3 does not function as an E3 ligase, we still
hypothesize that hmgb3 may function as a co-factor of ubc9 to
regulate retinal progenitor proliferation. In addition, our current study
implies that hmgb3 and ubc9 have functional associations regulating
the proliferation of progenitor/stem cells in various tissues as well.
Future studies are needed for further elucidation of these hypotheses.
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